Intravenous Immunoglobulin Market - Forecast(2021 - 2026)

Report Code: HCR 74678 Report Format: PDF + Excel (Delivery in 48 Hrs)

Intravenous Immunoglobulin Market Overview                                      

Intravenous Immunoglobulin Market size is estimated to reach $17.1 billion by 2026, growing at a CAGR of 7.5% during the forecast period 2021-2026. Intravenous Immunoglobulins are antibodies that are part of the blood's plasma and are produced naturally by the body's immune system. Intravenous Immunoglobulin (IVIG) is a therapy treatment for patients with various immunodeficiency diseases and bleeding disorders. These are glycoproteins made by the immune system of healthy people for fighting infections. It works in different ways to decrease inflammation in the body. Rise in the adoption of glycoproteins for the treatment of various immunodeficiency diseases, growing demand for immunoglobulin G (IgG) for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) and hypogammaglobulinemia, and increasing awareness about the efficiency of intravenous immunoglobulins as a treatment option are the factors that are set to drive the growth of the Intravenous Immunoglobulin Market for the period 2021-2026.

Intravenous Immunoglobulin Market Report Coverage

The report: Intravenous Immunoglobulin Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Intravenous Immunoglobulin Market.

By Product Type: Immunoglobulin G (IgG), Immunoglobulin A (IgA), Immunoglobulin M (IgM), Immunoglobulin E (IgE), and Immunoglobulin D (IgD).
By Application: Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Inflammatory Myopathies, Guillain-Barre Syndrome, Specific Antibody Deficiency, and Others.
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World (Middle East and Africa).

Key Takeaways

  • Geographically, North America Intravenous Immunoglobulin Market accounted for the highest revenue share in 2020 and it is poised to dominate over the period 2021-2026 owing to the growing adoption of glycoproteins for the treatment of various immunodeficiency diseases.
  • The rise in the applications of Immunoglobulin G (IgG) for the treatment of hypogammaglobulinemia is driving the Immunoglobulin G (IgG) segment. However, the high cost of intravenous immunoglobulin therapy is one of the major factors that is said to reduce the growth of the Intravenous Immunoglobulin Market.
  • Detailed analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Intravenous Immunoglobulin Market report.

Intravenous Immunoglobulin Market Size, By Product Type, 2020-2026 (USD Million)

For more details on this report - Request for Sample

Intravenous Immunoglobulin Market Segment Analysis-By Product Type

The Intravenous Immunoglobulin Market based on the Product Type can be further segmented into Immunoglobulin G (IgG), Immunoglobulin A (IgA), Immunoglobulin M (IgM), Immunoglobulin E (IgE), and Immunoglobulin D (IgD). The Immunoglobulin G (IgG) segment held the largest share in 2020 owing to its ability to control infection of body tissues and to protect the body from infection by binding many kinds of pathogens, such as viruses and fungi. 

The rise in the applications of Immunoglobulin G (IgG) for the treatment of hypogammaglobulinemia is driving the growth of the Intravenous Immunoglobulin Market. The Immunoglobulin A (IgA) segment is estimated to be the fastest growing segment with a CAGR of 8.3% over the period 2021-2026. This growth is owing to its ability to inhibit bacterial adhesion to epithelial cells and neutralize both bacterial and virus toxins. Immunoglobulin A (IgA) also acts as the first line of defense in the resistance against infection.

Intravenous Immunoglobulin Market Segment Analysis-By Application

The Intravenous Immunoglobulin Market based on the Application can be further segmented into Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Inflammatory Myopathies, Guillain-Barre Syndrome, Specific Antibody Deficiency, and Others. The Hypogammaglobulinemia segment held the largest share in 2020 and is also estimated to be the fastest growing segment with a CAGR of 8.4% over the period 2021-2026. This growth is owing to the factors such as the growing prevalence of hypogammaglobulinemia across the world and the rise in the research and development activities by the key players to developed advanced therapies for the treatment of hypogammaglobulinemia

The rise in the adoption of intravenous immunoglobulins for the treatment of hypogammaglobulinemia is driving the growth of the Intravenous Immunoglobulin Market. The Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) segment held the second largest share in 2020 owing to the factors such as increase in the prevalence of diabetes mellitus and growing awareness among the consumers about the benefits of minimally invasive and user-friendly procedures for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP).

Intravenous Immunoglobulin Market Segment Analysis-By Geography

North America held the largest share with 29% of the overall market in 2020. The growth in this segment can be attributed to the factors such as increase in the demand for immunoglobulin G (IgG) for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) and rise in the research and development activities by the key players to developed advanced therapies for the treatment of hypogammaglobulinemia

The rise in the adoption of glycoproteins for the treatment of various immunodeficiency diseases is driving the growth of the Intravenous Immunoglobulin Market. Asia-Pacific segment is estimated to be the fastest growing segment over the period 2021-2026. The growth in this segment is owing to the factors such as growing awareness about the efficiency of intravenous immunoglobulins as a treatment option and the rise in the adoption of advanced technologies pertaining to immunoglobulin production.

Intravenous Immunoglobulin Market Drivers

Rise in the Adoption of Immunoglobulin Treatment for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Intravenous Immunoglobulins are increasingly being used for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) owing to its associated benefits such as minimally invasive and user-friendly treatment options. These glycoproteins act as a critical part of the immune response by specifically binding to particular antigens, which is one of the major factors driving the growth of the Intravenous Immunoglobulin Market.

Increase in the Prevalence of Immunodeficiency Diseases and Bleeding Disorders

With an increase in the prevalence of immunodeficiency diseases and bleeding disorders across the world, there is an increase in the awareness among consumers about the efficiency of intravenous immunoglobulins as a treatment option. The key players are also focusing on developed advanced intravenous immunoglobulins for the treatment of various immunodeficiency diseases, which is further propelling the growth of the Intravenous Immunoglobulin Market.

Intravenous Immunoglobulin Market Challenges  

High Cost of Intravenous Immunoglobulin Therapy

The government of several nations and other organizations are increasing their initiatives to enhance awareness among people about immunodeficiency diseases and the efficiency of various intravenous immunoglobulins as a treatment option. However, the high cost of Intravenous Immunoglobulin therapy is one of the major factors that is estimated to reduce the growth of the Intravenous Immunoglobulin Market.

Intravenous Immunoglobulin Market Competitive Landscape

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Intravenous Immunoglobulin Market. Key companies of this market include Baxter International Inc, Takeda Pharmaceuticals, Bayer Healthcare, AscellaHealth, Kedrion Biopharma, Grifols, Biotest AG, Octapharma AG, LFB group, and Kedrion Biopharma Inc among others.

Partnerships/Product Launches

  • In November 2020, AscellaHealth has launched its Intravenous Immunoglobulin (IVIG) Medication Therapy to support the aim of the Immune Deficiency Foundation (IDF) and to enhance patient care and cost management approaches.
  • In June 2020, Grifols has launched its hyperimmune immunoglobulin for the treatment of infections that are applied to healthcare emergencies like the Ebola outbreak and to prevent infections in cases of accidental exposure to infectious agents associated with autoimmune diseases.
  • In April 2020, Kedrion Biopharma has entered into a partnership with Kamada for the Development, and Distribution of Intravenous Immunoglobulin to make a significant impact for patients in need during the pandemic.

Relevant Reports:

Monoclonal Antibodies Market - Forecast (2021 - 2026)

Report Code: HCR 0320

Injectable Drug Delivery Market - Forecast (2021 - 2026)

Report Code: HCR 0023

For more Lifesciences and Healthcare Market reports, please click here

1. Intravenous Immunoglobulin Market - Overview
    1.1 Definitions and Scope
2. Intravenous Immunoglobulin Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Product Type
    2.3 Key trends by Application
    2.4 Key trends by Geography
3. Intravenous Immunoglobulin Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Intravenous Immunoglobulin Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Intravenous Immunoglobulin Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Intravenous Immunoglobulin Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Intravenous Immunoglobulin Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Intravenous Immunoglobulin Market – By Product Type(Market Size –$Million/$Billion)
    8.1 Immunoglobulin G (IgG)
    8.2 Immunoglobulin A (IgA)
    8.3 Immunoglobulin M (IgM)
    8.4 Immunoglobulin E (IgE)
    8.5 Immunoglobulin D (IgD)
9. Intravenous Immunoglobulin Market – By Application(Market Size –$Million/$Billion)
    9.1 Hypogammaglobulinemia
    9.2 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
    9.3 Inflammatory Myopathies
    9.4 Guillain-Barre Syndrome
    9.5 Specific Antibody Deficiency
    9.6 Others
10. Intravenous Immunoglobulin Market - By Geography(Market Size –$Million/$Billion)
    10.1 North America
        10.1.1 U.S.
        10.1.2 Mexico
        10.1.3 Canada
    10.2 Europe
        10.2.1 U.K.
        10.2.2 France
        10.2.3 Germany
        10.2.4 Italy
        10.2.5 Spain
        10.2.6 Russia
        10.2.7 Rest of Europe
    10.3 Asia Pacific
        10.3.1 China
        10.3.2 India
        10.3.3 Japan
        10.3.4 South Korea
        10.3.5 Australia & New Zealand
        10.3.6 Rest of Asia Pacific
    10.4 South America
        10.4.1 Brazil
        10.4.2 Argentina
        10.4.3 Rest of South America
    10.5 Rest of the World
        10.5.1 Middle East
        10.5.2 Africa
11. Intravenous Immunoglobulin Market - Entropy
12. Intravenous Immunoglobulin Market – Industry/Segment Competition Landscape Premium
    12.1 Market Share Analysis
        12.1.1 Global Market Share – Key Companies
        12.1.2 Market Share by Region – Key companies
        12.1.3 Market Share by Countries – Key Companies
        12.1.4 Best Practices for Companies
13. Intravenous Immunoglobulin Market – Key Company List by Country Premium Premium
14. Intravenous Immunoglobulin Market Company Analysis
    14.1 Company 1
    14.2 Company 2
    14.3 Company 3
    14.4 Company 4
    14.5 Company 5
    14.6 Company 6
    14.7 Company 7
    14.8 Company 8
    14.9 Company 9
    14.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global IMMUNOGLOBULIN MARKET, BY PRODUCT Market 2019-2024 ($M)
1.1 IGG Market 2019-2024 ($M) - Global Industry Research
1.2 Clinical interpretations Market 2019-2024 ($M) - Global Industry Research
1.3 IGA Market 2019-2024 ($M) - Global Industry Research
1.4 Clinical interpretation Market 2019-2024 ($M) - Global Industry Research
1.5 IGM Market 2019-2024 ($M) - Global Industry Research
1.6 Clinical interpretation Market 2019-2024 ($M) - Global Industry Research
1.7 IGE Market 2019-2024 ($M) - Global Industry Research
1.7.1 Key Market Trend Market 2019-2024 ($M)
1.8 Clinical interpretation Market 2019-2024 ($M) - Global Industry Research
1.9 IGD Market 2019-2024 ($M) - Global Industry Research
1.10 Clinical interpretation Market 2019-2024 ($M) - Global Industry Research
2.Global IMMUNOGLOBULIN MARKET, BY PRODUCT Market 2019-2024 (Volume/Units)
2.1 IGG Market 2019-2024 (Volume/Units) - Global Industry Research
2.2 Clinical interpretations Market 2019-2024 (Volume/Units) - Global Industry Research
2.3 IGA Market 2019-2024 (Volume/Units) - Global Industry Research
2.4 Clinical interpretation Market 2019-2024 (Volume/Units) - Global Industry Research
2.5 IGM Market 2019-2024 (Volume/Units) - Global Industry Research
2.6 Clinical interpretation Market 2019-2024 (Volume/Units) - Global Industry Research
2.7 IGE Market 2019-2024 (Volume/Units) - Global Industry Research
2.7.1 Key Market Trend Market 2019-2024 (Volume/Units)
2.8 Clinical interpretation Market 2019-2024 (Volume/Units) - Global Industry Research
2.9 IGD Market 2019-2024 (Volume/Units) - Global Industry Research
2.10 Clinical interpretation Market 2019-2024 (Volume/Units) - Global Industry Research
3.North America IMMUNOGLOBULIN MARKET, BY PRODUCT Market 2019-2024 ($M)
3.1 IGG Market 2019-2024 ($M) - Regional Industry Research
3.2 Clinical interpretations Market 2019-2024 ($M) - Regional Industry Research
3.3 IGA Market 2019-2024 ($M) - Regional Industry Research
3.4 Clinical interpretation Market 2019-2024 ($M) - Regional Industry Research
3.5 IGM Market 2019-2024 ($M) - Regional Industry Research
3.6 Clinical interpretation Market 2019-2024 ($M) - Regional Industry Research
3.7 IGE Market 2019-2024 ($M) - Regional Industry Research
3.7.1 Key Market Trend Market 2019-2024 ($M)
3.8 Clinical interpretation Market 2019-2024 ($M) - Regional Industry Research
3.9 IGD Market 2019-2024 ($M) - Regional Industry Research
3.10 Clinical interpretation Market 2019-2024 ($M) - Regional Industry Research
4.South America IMMUNOGLOBULIN MARKET, BY PRODUCT Market 2019-2024 ($M)
4.1 IGG Market 2019-2024 ($M) - Regional Industry Research
4.2 Clinical interpretations Market 2019-2024 ($M) - Regional Industry Research
4.3 IGA Market 2019-2024 ($M) - Regional Industry Research
4.4 Clinical interpretation Market 2019-2024 ($M) - Regional Industry Research
4.5 IGM Market 2019-2024 ($M) - Regional Industry Research
4.6 Clinical interpretation Market 2019-2024 ($M) - Regional Industry Research
4.7 IGE Market 2019-2024 ($M) - Regional Industry Research
4.7.1 Key Market Trend Market 2019-2024 ($M)
4.8 Clinical interpretation Market 2019-2024 ($M) - Regional Industry Research
4.9 IGD Market 2019-2024 ($M) - Regional Industry Research
4.10 Clinical interpretation Market 2019-2024 ($M) - Regional Industry Research
5.Europe IMMUNOGLOBULIN MARKET, BY PRODUCT Market 2019-2024 ($M)
5.1 IGG Market 2019-2024 ($M) - Regional Industry Research
5.2 Clinical interpretations Market 2019-2024 ($M) - Regional Industry Research
5.3 IGA Market 2019-2024 ($M) - Regional Industry Research
5.4 Clinical interpretation Market 2019-2024 ($M) - Regional Industry Research
5.5 IGM Market 2019-2024 ($M) - Regional Industry Research
5.6 Clinical interpretation Market 2019-2024 ($M) - Regional Industry Research
5.7 IGE Market 2019-2024 ($M) - Regional Industry Research
5.7.1 Key Market Trend Market 2019-2024 ($M)
5.8 Clinical interpretation Market 2019-2024 ($M) - Regional Industry Research
5.9 IGD Market 2019-2024 ($M) - Regional Industry Research
5.10 Clinical interpretation Market 2019-2024 ($M) - Regional Industry Research
6.APAC IMMUNOGLOBULIN MARKET, BY PRODUCT Market 2019-2024 ($M)
6.1 IGG Market 2019-2024 ($M) - Regional Industry Research
6.2 Clinical interpretations Market 2019-2024 ($M) - Regional Industry Research
6.3 IGA Market 2019-2024 ($M) - Regional Industry Research
6.4 Clinical interpretation Market 2019-2024 ($M) - Regional Industry Research
6.5 IGM Market 2019-2024 ($M) - Regional Industry Research
6.6 Clinical interpretation Market 2019-2024 ($M) - Regional Industry Research
6.7 IGE Market 2019-2024 ($M) - Regional Industry Research
6.7.1 Key Market Trend Market 2019-2024 ($M)
6.8 Clinical interpretation Market 2019-2024 ($M) - Regional Industry Research
6.9 IGD Market 2019-2024 ($M) - Regional Industry Research
6.10 Clinical interpretation Market 2019-2024 ($M) - Regional Industry Research
7.MENA IMMUNOGLOBULIN MARKET, BY PRODUCT Market 2019-2024 ($M)
7.1 IGG Market 2019-2024 ($M) - Regional Industry Research
7.2 Clinical interpretations Market 2019-2024 ($M) - Regional Industry Research
7.3 IGA Market 2019-2024 ($M) - Regional Industry Research
7.4 Clinical interpretation Market 2019-2024 ($M) - Regional Industry Research
7.5 IGM Market 2019-2024 ($M) - Regional Industry Research
7.6 Clinical interpretation Market 2019-2024 ($M) - Regional Industry Research
7.7 IGE Market 2019-2024 ($M) - Regional Industry Research
7.7.1 Key Market Trend Market 2019-2024 ($M)
7.8 Clinical interpretation Market 2019-2024 ($M) - Regional Industry Research
7.9 IGD Market 2019-2024 ($M) - Regional Industry Research
7.10 Clinical interpretation Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Intravenous Immunoglobulin Market Revenue, 2019-2024 ($M)
2.Canada Intravenous Immunoglobulin Market Revenue, 2019-2024 ($M)
3.Mexico Intravenous Immunoglobulin Market Revenue, 2019-2024 ($M)
4.Brazil Intravenous Immunoglobulin Market Revenue, 2019-2024 ($M)
5.Argentina Intravenous Immunoglobulin Market Revenue, 2019-2024 ($M)
6.Peru Intravenous Immunoglobulin Market Revenue, 2019-2024 ($M)
7.Colombia Intravenous Immunoglobulin Market Revenue, 2019-2024 ($M)
8.Chile Intravenous Immunoglobulin Market Revenue, 2019-2024 ($M)
9.Rest of South America Intravenous Immunoglobulin Market Revenue, 2019-2024 ($M)
10.UK Intravenous Immunoglobulin Market Revenue, 2019-2024 ($M)
11.Germany Intravenous Immunoglobulin Market Revenue, 2019-2024 ($M)
12.France Intravenous Immunoglobulin Market Revenue, 2019-2024 ($M)
13.Italy Intravenous Immunoglobulin Market Revenue, 2019-2024 ($M)
14.Spain Intravenous Immunoglobulin Market Revenue, 2019-2024 ($M)
15.Rest of Europe Intravenous Immunoglobulin Market Revenue, 2019-2024 ($M)
16.China Intravenous Immunoglobulin Market Revenue, 2019-2024 ($M)
17.India Intravenous Immunoglobulin Market Revenue, 2019-2024 ($M)
18.Japan Intravenous Immunoglobulin Market Revenue, 2019-2024 ($M)
19.South Korea Intravenous Immunoglobulin Market Revenue, 2019-2024 ($M)
20.South Africa Intravenous Immunoglobulin Market Revenue, 2019-2024 ($M)
21.North America Intravenous Immunoglobulin By Application
22.South America Intravenous Immunoglobulin By Application
23.Europe Intravenous Immunoglobulin By Application
24.APAC Intravenous Immunoglobulin By Application
25.MENA Intravenous Immunoglobulin By Application
26.BAXTER INTERNATIONAL INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.BAYER AG, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.BIOTEST AG, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.CHINA BIOLOGIC PRODUCTS, INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.CSL LIMITED, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.GRIFOLS S.A., Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.KEDRION BIOPHARMA INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.LFB SA, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.OCTAPHARMA AG, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.TAKEDA PHARMACEUTICAL COMPANY LIMITED, Sales /Revenue, 2015-2018 ($Mn/$Bn)